Commitments and Contingencies (Details Narrative) - USD ($)				1 Months Ended
	Jul. 20, 2022	Aug. 24, 2021	Jul. 28, 2021	Feb. 16, 2022	Nov. 17, 2021
Licensing Agreement MLR1019 [Member]
Loss Contingencies [Line Items]
Debt Instrument, Periodic Payment			$ 21,800,000
Gross sales percentage			5.00%
Option purchase percentage			10.00%
Royalty gross sales percentage			2.50%
Licensing Agreement MLR1019 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Gross sales percentage		8.00%
Licensing Agreement MLR1019 [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Gross sales percentage		12.00%
Licensing Agreement MLR1023 [Member]
Loss Contingencies [Line Items]
Debt Instrument, Periodic Payment		$ 21,800,000
License agreement commitments description		if the Company failed to raise $4.0 million dollars within 120 days of the Effective Date of the agreement then the License would immediately terminate unless, by 120 Days Adhera was in the process of completing transactions to complete the fundraising then an additional 30 Days would be provided to allow for the completion of the raise		the Company and Melior I, extending the requirement by the Company to raise $4.0 million dollars to June 16, 2022	the Company’s timeline from 120 days to 180 days from the effective of the agreement for the Company to raise $4.0 million dollars unless, by 180 Days Adhera is in the process of completing transactions to complete the fundraising then an additional 30 Days shall be provided to allow for the completion of required fundraising
Licensing agreement [Member]
Loss Contingencies [Line Items]
Payment for licensing agreement	$ 136,921
Licensing agreement [Member] | Chief Scientific Officer [Member]
Loss Contingencies [Line Items]
Capital raise in additional	$ 500,000